Correlation between circulating fibrocytes and dermal thickness in limited cutaneous systemic sclerosis patients: a pilot study.
Aged
Biomarkers
/ blood
Case-Control Studies
Cell Count
Cells, Cultured
Cross-Sectional Studies
Dermis
/ diagnostic imaging
Disease Progression
Female
Humans
Male
Microscopic Angioscopy
Middle Aged
Pilot Projects
Predictive Value of Tests
Scleroderma, Systemic
/ blood
Severity of Illness Index
Stem Cells
/ metabolism
Ultrasonography
Fibrocytes
High-frequency ultrasound
Modified Rodnan skin score
Systemic sclerosis
Journal
Rheumatology international
ISSN: 1437-160X
Titre abrégé: Rheumatol Int
Pays: Germany
ID NLM: 8206885
Informations de publication
Date de publication:
Aug 2019
Aug 2019
Historique:
received:
16
03
2019
accepted:
26
04
2019
pubmed:
6
5
2019
medline:
11
3
2020
entrez:
7
5
2019
Statut:
ppublish
Résumé
The objective is to detect any possible correlation between the modified Rodnan skin score (mRSS) and dermal thickness (DT) measured by skin high-frequency ultrasound (US) and the percentage of circulating fibrocytes in patients with limited cutaneous systemic sclerosis (lcSSc). Eight lcSSc patients and five healthy subjects (control group, CNT) were enrolled. The skin involvement was evaluated by mRSS and US (18 and 22 MHz probes) in all 13 subjects in the 17 standard skin areas evaluated by mRss. Circulating fibrocytes were isolated from the peripheral blood mononuclear cells (PBMCs) of all lcSSc patients and the CNT group to analyze their percentage at baseline time (T0) when the experiments started with PBMCs' isolation and collection and after 8 days of culture (T8). Non-parametric tests were used for the statistical analysis. A positive correlation between the percentage of circulating fibrocytes at T0, mRSS (p = 0.04 r = 0.96), and DT-US, evaluated by the 22 MHz and the 18 MHz probes (p = 0.03, r = 0.66 and p = 0.05, r = 0.52, respectively), was observed in lcSSc patients. Conversely, at T8, there was no correlation (p > 0.05) between these parameters in lcSSc group. In the CNT group, no correlations between mRSS or DT-US and the percentage of circulating fibrocytes were observed both at T0 and T8. The study shows the presence of a significant relationship between the percentage of circulating fibrocytes and DT, as evidenced by both mRSS and US, in limited cutaneus SSc. This observation may well suggest the reasonable hypothesis of a crucial contribution of circulating fibrocytes to skin fibrosis progression, which might be considered as further biomarkers.
Identifiants
pubmed: 31056725
doi: 10.1007/s00296-019-04315-7
pii: 10.1007/s00296-019-04315-7
doi:
Substances chimiques
Biomarkers
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1369-1376Références
J Rheumatol. 2000 Jan;27(1):155-60
pubmed: 10648032
J Immunol. 2001 Jun 15;166(12):7556-62
pubmed: 11390511
Methods. 2001 Dec;25(4):402-8
pubmed: 11846609
Rheumatology (Oxford). 2003 Dec;42(12):1559-63
pubmed: 12867579
J Clin Invest. 2004 Aug;114(3):438-46
pubmed: 15286810
Exp Cell Res. 2005 Mar 10;304(1):81-90
pubmed: 15707576
Am J Pathol. 2005 Mar;166(3):675-84
pubmed: 15743780
Clin Rheumatol. 2007 Jul;26(7):1136-41
pubmed: 17061153
Ann Rheum Dis. 2007 Jul;66(7):966-9
pubmed: 17234649
Ann Rheum Dis. 2008 Jun;67(6):885-7
pubmed: 18037628
J Am Coll Radiol. 2008 Jan;5(1):36-9
pubmed: 18180007
J Cell Mol Med. 2008 Jan-Feb;12(1):22-37
pubmed: 18182061
Thromb Haemost. 2009 Apr;101(4):613-8
pubmed: 19350102
J Rheumatol. 2009 Jun;36(6):1235-9
pubmed: 19369451
Rheumatology (Oxford). 2009 Jun;48 Suppl 3:iii14-8
pubmed: 19487217
J Leukoc Biol. 2009 Nov;86(5):1111-8
pubmed: 19581373
Rheumatology (Oxford). 2009 Sep;48(9):1143-6
pubmed: 19605370
Ann Rheum Dis. 2010 Jun;69(6):1140-3
pubmed: 19762365
Am J Pathol. 2010 Apr;176(4):1735-42
pubmed: 20150435
Nat Rev Rheumatol. 2010 Oct;6(10):578-87
pubmed: 20703220
Nat Rev Immunol. 2011 Jun;11(6):427-35
pubmed: 21597472
J Leukoc Biol. 2013 Jan;93(1):45-50
pubmed: 22993208
Fibrogenesis Tissue Repair. 2012 Jun 06;5(Suppl 1):S5
pubmed: 23259712
Fibrogenesis Tissue Repair. 2012 Jun 06;5(Suppl 1):S6
pubmed: 23259722
Ann Rheum Dis. 2014 Jan;73(1):247-51
pubmed: 23644551
Ann Rheum Dis. 2013 Nov;72(11):1747-55
pubmed: 24092682
Adv Wound Care (New Rochelle). 2012 Feb;1(1):36-40
pubmed: 24527276
Eur Respir Rev. 2015 Mar;24(135):102-14
pubmed: 25726561
J Allergy Clin Immunol. 2016 Apr;137(4):1036-1042.e7
pubmed: 26602164
Mol Med. 2015 Oct 27;21 Suppl 1:S3-5
pubmed: 26605645
F1000Res. 2016 Apr 22;5:null
pubmed: 27158466
J Mol Cell Cardiol. 2016 Aug;97:153-61
pubmed: 27167848
Clin Rheumatol. 2017 Jul;36(7):1637-1642
pubmed: 27722973
Medicine (Baltimore). 2017 Jun;96(26):e7400
pubmed: 28658176
Respir Res. 2017 Jul 18;18(1):141
pubmed: 28720095
Microvasc Res. 2018 Jan;115:28-33
pubmed: 28834709
J Invest Dermatol. 2018 Jan;138(1):240-242
pubmed: 28867656
Arthritis Res Ther. 2018 May 2;20(1):77
pubmed: 29720235
Arthritis Care Res (Hoboken). 2019 Apr;71(4):563-574
pubmed: 29781576
Arthritis Res Ther. 2018 Jul 27;20(1):157
pubmed: 30053831
Arthritis Res Ther. 2018 Aug 16;20(1):181
pubmed: 30115105
Cell Physiol Biochem. 2018;49(3):848-868
pubmed: 30184544
Clin Rheumatol. 2018 Nov;37(11):3057-3062
pubmed: 30291470
J Rheumatol. 1995 Jul;22(7):1281-5
pubmed: 7562759